AYK004 is an adenosine derivative that functions as a TLR7/8 agonist, enhancing immune responses by activating the TLR signaling pathway. It boasts an optimal hydrophilic-lipophilic balance, improving its loading rate and stability within immunoadjuvant systems like liposomes, and reduces the side effects of these systems during systemic immunization.